HomeANAB • BMV
add
AnaptysBio Inc
Previous close
$580.00
Year range
$580.00 - $580.00
Market cap
578.14M USD
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 30.02M | 804.67% |
Operating expense | 10.56M | 3.83% |
Net income | -32.85M | 11.95% |
Net profit margin | -109.44 | 90.27% |
Earnings per share | -1.14 | 19.15% |
EBITDA | -22.61M | 39.82% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 430.12M | 4.13% |
Total assets | 493.42M | 1.25% |
Total liabilities | 409.05M | 11.48% |
Total equity | 84.37M | — |
Shares outstanding | 30.43M | — |
Price to book | 209.39 | — |
Return on assets | -12.36% | — |
Return on capital | -13.54% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -32.85M | 11.95% |
Cash from operations | -10.09M | 72.34% |
Cash from investing | 58.62M | 91.35% |
Cash from financing | 71.23M | 2,418.68% |
Net change in cash | 119.76M | 1,443.96% |
Free cash flow | -13.70M | 48.31% |
About
Founded
2005
Headquarters
Website
Employees
117
